pathway,nums,percent,pvalue
Metabolic pathways,1315,0.38631178707224334,0.0
Retinol metabolism,97,0.25773195876288657,0.0
Steroid hormone biosynthesis,96,0.3020833333333333,0.0
Biosynthesis of cofactors,152,0.17763157894736842,0.003
Taurine and hypotaurine metabolism,22,0.13636363636363635,0.011
Purine metabolism,185,0.10810810810810811,0.012
Synthesis and degradation of ketone bodies,11,0.2727272727272727,0.018
Ovarian steroidogenesis,65,0.046153846153846156,0.02
"Valine, leucine and isoleucine degradation",57,0.05263157894736842,0.02
Pyrimidine metabolism,107,0.14953271028037382,0.025
Epstein-Barr virus infection,230,0.09565217391304348,0.025
Nucleotide metabolism,84,0.10714285714285714,0.026
Chemical carcinogenesis - receptor activation,225,0.12444444444444444,0.028
Spliceosome,186,0.1774193548387097,0.033
Amyotrophic lateral sclerosis,369,0.18699186991869918,0.036
Polycomb repressive complex,84,0.16666666666666666,0.039
Glutathione metabolism,74,0.04054054054054054,0.048
Cortisol synthesis and secretion,72,0.041666666666666664,0.048
Aldosterone synthesis and secretion,105,0.02857142857142857,0.05
Linoleic acid metabolism,50,0.16,0.05
Hypertrophic cardiomyopathy,91,0.03296703296703297,0.059
Calcium signaling pathway,254,0.05511811023622047,0.06
Chemical carcinogenesis - DNA adducts,84,0.20238095238095238,0.07
Hypertrophic cardiomyopathy (HCM),84,0.03571428571428571,0.076
"Ascorbate biosynthesis, animals, glucose-1P => ascorbate",24,0.20833333333333334,0.08
Dilated cardiomyopathy,94,0.031914893617021274,0.082
Neutrophil extracellular trap formation,208,0.0625,0.083
Nicotinate and nicotinamide metabolism,45,0.13333333333333333,0.084
Huntington's disease,194,0.03608247422680412,0.086
Parkinson's disease,144,0.041666666666666664,0.089
PPAR signaling pathway,90,0.044444444444444446,0.091
Inositol phosphate metabolism,73,0.0684931506849315,0.093
Adrenergic signaling in cardiomyocytes,156,0.019230769230769232,0.095
Ubiquitin mediated proteolysis,151,0.09933774834437085,0.096
Cellular senescence,183,0.02185792349726776,0.099
Diabetic cardiomyopathy,211,0.02843601895734597,0.106
Huntington disease,302,0.08940397350993377,0.107
Cushing syndrome,162,0.030864197530864196,0.117
Cardiac muscle contraction,87,0.05747126436781609,0.134
Salmonella infection,253,0.11067193675889328,0.14
Complement and coagulation cascades,94,0.3617021276595745,0.143
Amyotrophic lateral sclerosis (ALS),52,0.057692307692307696,0.145
Drug metabolism - cytochrome P450,72,0.05555555555555555,0.145
Ascorbate and aldarate metabolism,31,0.1935483870967742,0.149
Galactose metabolism,34,0.08823529411764706,0.151
Porphyrin metabolism,43,0.09302325581395349,0.154
Prion disease,267,0.1348314606741573,0.155
mTOR signaling pathway,158,0.06962025316455696,0.157
IL-17 signaling pathway,93,0.03225806451612903,0.176
Starch and sucrose metabolism,36,0.08333333333333333,0.177
Sphingolipid signaling pathway,127,0.05511811023622047,0.179
PD-L1 expression and PD-1 checkpoint pathway in cancer,88,0.03409090909090909,0.179
Spinocerebellar ataxia,141,0.12056737588652482,0.183
Endocytosis,297,0.1111111111111111,0.187
Phosphatidylinositol signaling system,99,0.04040404040404041,0.191
Pentose and glucuronate interconversions,37,0.08108108108108109,0.192
Glucuronate pathway (uronate pathway),26,0.11538461538461539,0.195
Porphyrin and chlorophyll metabolism,41,0.07317073170731707,0.195
Pathways of neurodegeneration - multiple diseases,471,0.1040339702760085,0.199
Coronavirus disease - COVID-19,249,0.20080321285140562,0.201
Drug metabolism - other enzymes,92,0.03260869565217391,0.202
RNA transport,167,0.1317365269461078,0.216
Nucleocytoplasmic transport,117,0.1623931623931624,0.216
Alzheimer disease,383,0.1122715404699739,0.227
Human papillomavirus infection,361,0.04155124653739612,0.228
Measles,145,0.020689655172413793,0.232
Signaling pathways regulating pluripotency of stem cells,141,0.15602836879432624,0.241
Viral carcinogenesis,228,0.03508771929824561,0.241
Cholesterol metabolism,50,0.22,0.25
Serotonergic synapse,133,0.03759398496240601,0.255
"Alanine, aspartate and glutamate metabolism",41,0.12195121951219512,0.265
Human T-cell leukemia virus 1 infection,249,0.07228915662650602,0.265
Neurotrophin signaling pathway,121,0.05785123966942149,0.27
Human immunodeficiency virus 1 infection,239,0.04602510460251046,0.274
Parkinson disease,264,0.0946969696969697,0.274
RIG-I-like receptor signaling pathway,73,0.1506849315068493,0.291
NF-kappa B signaling pathway,114,0.043859649122807015,0.294
Nucleotide excision repair,58,0.05172413793103448,0.295
Osteoclast differentiation,140,0.05,0.298
Colorectal cancer,88,0.07954545454545454,0.298
Arachidonic acid metabolism,95,0.07368421052631578,0.322
Human cytomegalovirus infection,255,0.011764705882352941,0.324
TGF-beta signaling pathway,112,0.16071428571428573,0.325
Bile secretion,100,0.18,0.328
Chemical carcinogenesis - reactive oxygen species,223,0.07174887892376682,0.329
Kaposi sarcoma-associated herpesvirus infection,223,0.026905829596412557,0.34
Oxytocin signaling pathway,154,0.01948051948051948,0.346
"Spliceosome, 35S U5-snRNP",36,0.08333333333333333,0.354
Autophagy - animal,167,0.1437125748502994,0.358
Carbohydrate digestion and absorption,49,0.10204081632653061,0.386
Pancreatic cancer,76,0.06578947368421052,0.387
Alcoholic liver disease,141,0.028368794326241134,0.398
Cell cycle,157,0.01910828025477707,0.399
mmuK signaling pathway,301,0.023255813953488372,0.409
Mitophagy - animal,68,0.07352941176470588,0.41
cGMP-PKG signaling pathway,175,0.08,0.419
Platinum drug resistance,80,0.0625,0.425
Lysine degradation,67,0.11940298507462686,0.432
2-Oxocarboxylic acid metabolism,34,0.14705882352941177,0.442
"Glycine, serine and threonine metabolism",40,0.225,0.449
Pentose phosphate pathway,34,0.08823529411764706,0.454
Biosynthesis of amino acids,84,0.03571428571428571,0.467
Pentose phosphate pathway (Pentose phosphate cycle),12,0.25,0.467
MicroRNAs in cancer,303,0.019801980198019802,0.476
Nuclear pore complex,41,0.0975609756097561,0.48
Pancreatic secretion,116,0.02586206896551724,0.484
Inflammatory mediator regulation of TRP channels,127,0.07086614173228346,0.487
MAPK signaling pathway,252,0.011904761904761904,0.488
Th1 and Th2 cell differentiation,89,0.033707865168539325,0.489
Ribosome biogenesis in eukaryotes,125,0.088,0.5
RNA degradation,90,0.03333333333333333,0.508
Transcriptional misregulation in cancer,224,0.022321428571428572,0.51
Arginine and proline metabolism,57,0.2982456140350877,0.517
"Exosome, eukaryotes",10,0.3,0.517
Chagas disease,103,0.02912621359223301,0.52
Tryptophan metabolism,54,0.16666666666666666,0.525
Wnt signaling pathway,180,0.05,0.528
HTLV-I infection,283,0.0636042402826855,0.532
HIF-1 signaling pathway,120,0.025,0.552
Herpes simplex virus 1 infection,458,0.05895196506550218,0.554
Activin signaling,10,0.4,0.555
Fanconi anemia pathway,51,0.058823529411764705,0.561
ATP-dependent chromatin remodeling,136,0.029411764705882353,0.564
Mismatch repair,22,0.18181818181818182,0.566
Adipocytokine signaling pathway,73,0.0410958904109589,0.574
Efferocytosis,155,0.05161290322580645,0.598
African trypanosomiasis,39,0.15384615384615385,0.606
Insulin resistance,110,0.02727272727272727,0.612
Systemic lupus erythematosus,149,0.020134228187919462,0.616
Carbon metabolism,126,0.14285714285714285,0.643
"Spliceosome, U4/U6.U5 tri-snRNP",32,0.09375,0.648
Regulation of actin cytoskeleton,239,0.1087866108786611,0.649
Necroptosis,175,0.06285714285714286,0.651
Hepatocellular carcinoma,174,0.017241379310344827,0.652
Platelet activation,126,0.12698412698412698,0.66
Thermogenesis,231,0.012987012987012988,0.664
Adherens junction,93,0.06451612903225806,0.665
Ferroptosis,42,0.07142857142857142,0.678
Toxoplasmosis,109,0.027522935779816515,0.678
Staphylococcus aureus infection,128,0.0390625,0.695
Peroxisome,87,0.04597701149425287,0.696
Metabolism of xenobiotics by cytochrome P450,75,0.10666666666666667,0.698
Cysteine and methionine metabolism,57,0.08771929824561403,0.699
Fluid shear stress and atherosclerosis,147,0.04081632653061224,0.703
"Ribosome, eukaryotes",98,0.030612244897959183,0.704
Thyroid hormone synthesis,74,0.05405405405405406,0.729
Neuroactive ligand-receptor interaction,393,0.015267175572519083,0.738
Amoebiasis,107,0.07476635514018691,0.746
Herpes simplex infection,215,0.08837209302325581,0.762
Cytokine-cytokine receptor interaction,326,0.06134969325153374,0.768
Ras signaling pathway,242,0.012396694214876033,0.769
Pathways in cancer,543,0.09392265193370165,0.778
Rap1 signaling pathway,218,0.027522935779816515,0.794
Ribosome,187,0.0481283422459893,0.811
"Growth hormone synthesis, secretion and action",117,0.08547008547008547,0.85
Motor proteins,196,0.08673469387755102,0.865
GABAergic synapse,91,0.054945054945054944,0.866
Homologous recombination,42,0.07142857142857142,0.866
Phagosome,192,0.020833333333333332,0.866
NOD-like receptor signaling pathway,220,0.05,0.876
Mineral absorption,56,0.07142857142857142,0.883
Glutamatergic synapse,116,0.02586206896551724,0.891
Influenza A,173,0.04046242774566474,0.898
Glucagon signaling pathway,108,0.027777777777777776,0.907
Insulin signaling pathway,143,0.02097902097902098,0.912
Autophagy - other,32,0.21875,0.923
PI3K-Akt signaling pathway,373,0.029490616621983913,0.927
FoxO signaling pathway,133,0.08270676691729323,0.929
Synaptic vesicle cycle,77,0.07792207792207792,0.937
DNA replication,35,0.11428571428571428,0.939
Prion diseases,34,0.20588235294117646,0.939
Toll-like receptor signaling pathway,104,0.028846153846153848,0.942
Hepatitis C,166,0.018072289156626505,0.948
Jak-STAT signaling pathway,159,0.05660377358490566,0.956
Tight junction,179,0.0223463687150838,0.956
Glyoxylate and dicarboxylate metabolism,32,0.15625,0.964
TNF signaling pathway,115,0.08695652173913043,0.964
Hepatitis B,163,0.024539877300613498,0.965
JAK-STAT signaling pathway,171,0.04678362573099415,0.974
Primary bile acid biosynthesis,18,0.3333333333333333,0.978
Vascular smooth muscle contraction,145,0.020689655172413793,0.98
Apoptosis,137,0.021897810218978103,0.985
Butanoate metabolism,28,0.10714285714285714,0.989
Chemokine signaling pathway,204,0.014705882352941176,0.992
Alzheimer's disease,175,0.02857142857142857,1.0
